The first generic versions of Roche's bone-strengthening drug Boniva have been approved by the U.S. Food and Drug Administration. Boniva, known generically as ibandronate, is taken once a month to ...

Generic Boniva approved for osteoporosis March 19, 2012 HealthDay News — The FDA has approved the first generic versions of the once-monthly osteoporosis drug ibandronate (Boniva, Genentech).

Osteoporosis drug Boniva, a GlaxoSmithKline (NYSE:GSK) and Roche (OTC:RHHBY) product, will soon face its first generic competitors. Mylan (NASDAQ:MYL), Apotex and Orchid Healthcare all received U ...

Patients who want an injectable form of Roche Holding AG's bone-strengthening drug Boniva may not be able to get it in the next few weeks because the company did not accurately forecast demand ...

Roche Holding AG, the maker of the tumor medicine Avastin, sued Teva Pharmaceuticals Industries Ltd. and three other companies to block U.S. sales of a generic version of Boniva, a once-a-month ...

(HealthDay) -- The first generic versions of the once-monthly osteoporosis drug Boniva (ibandronate) have been approved by the U.S. Food and Drug Administration.

@FiercePharma: Derek Lowe's take on the GSK-won't-buy-AstraZeneca story. Hint: Fig Newtons figure in. More | Follow @FiercePharma @EricPFierce: FDA says drugs shortages are down ...

The drug is a generic version of Boniva. The branded drug and generic versions had U.S. sales of approximately $486 million during the 12-month period ended in March, according to IMS Health.

FDA approves first Boniva generics to treat or prevent osteoporosis. For Immediate Release: March 19, 2012 Media Inquiries: Sandy Walsh, 301-796-4669, [email protected] Consumer Inquiries: 888 ...

Watch our Boniva Adwatch video (above), read more about drug ads, and watch our Adwatch videos on Chantix, Cialis, Seasonique, Rozerem, and Requip. E-mail Newsletters FREE e-mail Newsletters!

Watson Pharmaceuticals Inc. recently announced that the US Food and Drug Administration has approved the company's abbreviated new drug application for a generic version of Roche Holding Ltd.'s ...

Patients who want an injectable form of Roche Holding AG's bone-strengthening drug Boniva may not be able to get it in the next few weeks because the company did not accurately forecast demand ...